The Latest Headlines at American Banking and Market News
AtriCure (NASDAQ:ATRC) Price Target Cut to $34.00
AtriCure (NASDAQ:ATRC – Free Report) had its target price lowered by JPMorgan Chase & Co. from $42.00 to $34.00 in a research report report published on Thursday, Benzinga reports. The firm currently has an overweight rating... More of this article »
Asure Software (NASDAQ:ASUR) Earns “Buy” Rating from Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Asure Software (NASDAQ:ASUR – Free Report) in a report released on Friday, Benzinga reports. They currently have a $20.00 price target on the technology company’s... More of this article »
Alnylam Pharmaceuticals’ (ALNY) Buy Rating Reiterated at Chardan Capital
Chardan Capital reissued their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report report published on Friday, Benzinga reports. Chardan Capital currently has a $225.00 price objective... More of this article »
Roth Capital Comments on Clearfield, Inc.’s Q2 2025 Earnings (NASDAQ:CLFD)
Clearfield, Inc. (NASDAQ:CLFD – Free Report) – Investment analysts at Roth Capital lowered their Q2 2025 earnings per share estimates for shares of Clearfield in a note issued to investors on Thursday, May 2nd. Roth... More of this article »
Q3 2025 EPS Estimates for The Travelers Companies, Inc. Boosted by Zacks Research (NYSE:TRV)
The Travelers Companies, Inc. (NYSE:TRV – Free Report) – Research analysts at Zacks Research upped their Q3 2025 EPS estimates for Travelers Companies in a research note issued to investors on Wednesday, May 1st. Zacks... More of this article »
Brokers Offer Predictions for Ardelyx, Inc.’s Q2 2025 Earnings (NASDAQ:ARDX)
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Equities researchers at Wedbush upped their Q2 2025 earnings per share (EPS) estimates for shares of Ardelyx in a research report issued to clients and investors on Thursday,... More of this article »
Zacks Research Weighs in on Southwestern Energy’s Q2 2025 Earnings (NYSE:SWN)
Southwestern Energy (NYSE:SWN – Free Report) – Equities researchers at Zacks Research raised their Q2 2025 EPS estimates for Southwestern Energy in a research note issued to investors on Wednesday, May 1st. Zacks Research... More of this article »
Thryv Holdings, Inc. Forecasted to Earn Q2 2025 Earnings of $0.40 Per Share (NASDAQ:THRY)
Thryv Holdings, Inc. (NASDAQ:THRY – Free Report) – Research analysts at William Blair raised their Q2 2025 EPS estimates for shares of Thryv in a research report issued on Thursday, May 2nd. William Blair analyst A.... More of this article »
Unity Software Inc. Forecasted to Post Q2 2025 Earnings of $0.03 Per Share (NYSE:U)
Unity Software Inc. (NYSE:U – Free Report) – Equities research analysts at Wedbush increased their Q2 2025 earnings per share (EPS) estimates for shares of Unity Software in a research note issued to investors on Thursday,... More of this article »
Alkermes plc (NASDAQ:ALKS) Expected to Post Q1 2025 Earnings of $0.43 Per Share
Alkermes plc (NASDAQ:ALKS – Free Report) – Stock analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Alkermes in a research note issued on Thursday, May 2nd. HC Wainwright analyst D. Tsao... More of this article »
Equities Analysts Offer Predictions for Blueprint Medicines Co.’s Q1 2025 Earnings (NASDAQ:BPMC)
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Equities research analysts at Wedbush issued their Q1 2025 earnings estimates for Blueprint Medicines in a research report issued to clients and investors on Thursday,... More of this article »
Q1 2025 Earnings Forecast for Customers Bancorp, Inc. Issued By Wedbush (NYSE:CUBI)
Customers Bancorp, Inc. (NYSE:CUBI – Free Report) – Analysts at Wedbush reduced their Q1 2025 earnings per share (EPS) estimates for Customers Bancorp in a research report issued to clients and investors on Thursday,... More of this article »
Zacks Research Analysts Cut Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Zacks Research decreased their Q1 2025 earnings per share estimates for Deciphera Pharmaceuticals in a report released on Wednesday, May 1st. Zacks Research... More of this article »